Anastasios Koutsopoulos

Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC

Aristea Kalikaki, Anastasios Koutsopoulos, Maria Trypaki et al. · British Journal of Cancer · 2008 · 207 citations · Full text

Medicine, Oncology, Pharmacology +16

Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts

Dimitra Kerdidani, Emmanouil Aerakis, Kleio‐Maria Verrou et al. · The Journal of Experimental Medicine · 2021 · 185 citations · Full text

Life Sciences, Immunology, Oncology +17

Tumor BRCA1, RRM1 and RRM2 mRNA Expression Levels and Clinical Response to First-Line Gemcitabine plus Docetaxel in Non-Small-Cell Lung Cancer Patients

Ioannis Boukovinas, Chara Papadaki, Pedro Méndez et al. · PLoS ONE · 2008 · 124 citations · Full text

Medicine, Oncology, Pharmacology +15

Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine

John Souglakos, Ioannis Boukovinas, Miquel Tarón et al. · British Journal of Cancer · 2008 · 117 citations · Full text

Medicine, Oncology, Pharmacology +12

‘Classical’ but not ‘other’ mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancer

Athanasios Pallis, Alexandra Voutsina, Ar Kalikaki et al. · British Journal of Cancer · 2007 · 92 citations · Full text

Medicine, Molecular Genetics, Oncology +17